CARA
Price
$0.97
Change
+$0.01 (+1.04%)
Updated
Nov 30, 6:59 PM EST
103 days until earnings call
TYRA
Price
$11.71
Change
+$0.66 (+5.97%)
Updated
Nov 30, 6:59 PM EST
90 days until earnings call
Ad is loading...

Compare trend and price CARA vs TYRA

Header iconCARA vs TYRA Comparison
Open Charts CARA vs TYRABanner chart's image
Cara Therapeutics
Price$0.97
Change+$0.01 (+1.04%)
Volume$274.67K
CapitalizationN/A
Tyra Biosciences
Price$11.71
Change+$0.66 (+5.97%)
Volume$14.06K
CapitalizationN/A
View a ticker or compare two or three
CARA vs TYRA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CARA vs. TYRA commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARA is a Hold and TYRA is a StrongBuy.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (CARA: $0.97 vs. TYRA: $11.71)
Brand notoriety: CARA and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARA: 75% vs. TYRA: 21%
Market capitalization -- CARA: $50.74M vs. TYRA: $482.69M
CARA [@Biotechnology] is valued at $50.74M. TYRA’s [@Biotechnology] market capitalization is $482.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARA’s FA Score shows that 0 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • CARA’s FA Score: 0 green, 5 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, TYRA is a better buy in the long-term than CARA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARA’s TA Score shows that 4 TA indicator(s) are bullish while TYRA’s TA Score has 4 bullish TA indicator(s).

  • CARA’s TA Score: 4 bullish, 3 bearish.
  • TYRA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both CARA and TYRA are a good buy in the short-term.

Price Growth

CARA (@Biotechnology) experienced а +0.48% price change this week, while TYRA (@Biotechnology) price change was +2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.54%. For the same industry, the average monthly price growth was +27.11%, and the average quarterly price growth was +23.26%.

Reported Earning Dates

CARA is expected to report earnings on Mar 13, 2024.

TYRA is expected to report earnings on Feb 29, 2024.

Industries' Descriptions

@Biotechnology (+2.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CARA with price predictions.
OPEN
A.I.dvisor published
a Summary for TYRA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TYRA($483M) has a higher market cap than CARA($50.7M). TYRA has higher P/E ratio than CARA: TYRA (21.79) vs CARA (19.53). TYRA YTD gains are higher at: 54.079 vs. CARA (-90.997). TYRA has higher annual earnings (EBITDA): -69M vs. CARA (-119.96M). TYRA has more cash in the bank: 216M vs. CARA (78.5M). TYRA has less debt than CARA: TYRA (6.11M) vs CARA (7.31M). CARA has higher revenues than TYRA: CARA (21.2M) vs TYRA (0).
CARATYRACARA / TYRA
Capitalization50.7M483M10%
EBITDA-119.96M-69M174%
Gain YTD-90.99754.079-168%
P/E Ratio19.5321.7990%
Revenue21.2M0-
Total Cash78.5M216M36%
Total Debt7.31M6.11M120%
FUNDAMENTALS RATINGS
CARA: Fundamental Ratings
CARA
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARATYRA
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend about 1 month ago
79%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
78%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCAT0.880.02
+2.30%
Red Cat Holdings
CSIQ21.030.12
+0.57%
Canadian Solar
SCM12.780.06
+0.47%
STELLUS CAPITAL INVESTMENT Corp
ACN333.14-0.20
-0.06%
Accenture PLC
WIX101.40-0.71
-0.70%
Wix.com Ltd

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with ORMP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
+5.97%
ORMP - TYRA
38%
Loosely correlated
+0.91%
SRNEQ - TYRA
36%
Loosely correlated
N/A
BBIO - TYRA
34%
Loosely correlated
+0.84%
XNCR - TYRA
32%
Poorly correlated
+0.11%
SAGE - TYRA
32%
Poorly correlated
+0.51%
More